Finanzwire Finanzwire
Basculer en Français
9984 Companies
202410 Keywords
133048 Articles
107493 Press releases
Headlines Articles Press releases Ascend Advanced Therapies (Ascend) Remove
  1. Home
  2. Companies
  3. Ascend Advanced Therapies (Ascend)
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/10/2025 at 18:10, 3 months 25 days ago

    Ascend's Innovation Enhances AAV Production Efficiency

    Gene Therapy Biotechnology Innovation Ascend Advanced Therapies AAV Production Manufacturing Enhancers
  • PRESS RELEASE

    published on 11/10/2025 at 18:05, 3 months 25 days ago

    Ascend Unveils Proprietary Enhancers That Significantly Improve AAV Yields Without Compromising Quality

    Ascend Advanced Therapies unveils proprietary enhancers demonstrating significant improvements in AAV yields and quality attributes for gene therapy programs
    Ascend Advanced Therapies Proprietary Enhancers AAV Yields Gene Therapy Programs Quality Attributes
    Logo of Ascend Advanced Therapies (Ascend)
  • BRIEF

    published on 10/08/2025 at 15:10, 4 months 28 days ago

    Ascend Advanced Therapies Successfully Defends EpyQ® Patent at EPO

    Intellectual Property Gene Therapy European Patent Office Ascend Advanced Therapies EpyQ® AAV Plasmid
  • PRESS RELEASE

    published on 10/08/2025 at 15:05, 4 months 28 days ago

    European Patent on Ascend Advanced Therapies' EpyQ® AAV Plasmid Technology Successfully Defended at the EPO

    Ascend Advanced Therapies successfully defends European patent EP3722434 for EpyQ® AAV plasmid technology at the EPO, reinforcing its position in gene therapy
    Gene Therapy European Patent Ascend Advanced Therapies EpyQ® AAV Plasmid Technology
    Logo of Ascend Advanced Therapies (Ascend)
Accesswire
  • Published on 03/05/2026 at 20:00, 50 minutes ago

    PPX Hosts Medical Outreach Campaign for Local Communities

  • Published on 03/05/2026 at 17:55, 2 hours 55 minutes ago

    ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026

  • Published on 03/05/2026 at 14:00, 6 hours 50 minutes ago

    EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada

  • Published on 03/05/2026 at 14:00, 6 hours 50 minutes ago

    GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report

  • Published on 03/05/2026 at 14:00, 6 hours 50 minutes ago

    Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters

View all ACCESSWIRE
EQS Group
  • Published on 03/05/2026 at 19:52, 57 minutes ago

    Northern Data provides operational update

  • Published on 03/05/2026 at 19:49, 1 hour 1 minute ago

    EQS-Adhoc:  Northern Data Announces Preliminary Q4 2025 revenue and FY 2026 outlook

  • Published on 03/05/2026 at 19:15, 1 hour 35 minutes ago

    Huawei Wins Eight GLOMO Awards at MWC Barcelona 2026

  • Published on 03/05/2026 at 19:05, 1 hour 45 minutes ago

    Supercharging Edge AI: Apacer Launches Industrial Grade Storage for Raspberry Pi Platforms

  • Published on 03/05/2026 at 18:48, 2 hours 2 minutes ago

    POS-Transaction in Own Shares

View all EQS
Les Echos
  • Published on 03/05/2026 at 18:40, 2 hours 10 minutes ago

    2025 Full-year results FREY: a pan-European platform already creating value

  • Published on 03/05/2026 at 18:34, 2 hours 15 minutes ago

    Mersen: Number of shares and voting rights as of February 28, 2026

  • Published on 03/05/2026 at 17:45, 3 hours 5 minutes ago

    February 2026

  • Published on 03/05/2026 at 17:45, 3 hours 5 minutes ago

    Cie du Bois Sauvage : Results 2025

  • Published on 03/05/2026 at 13:20, 7 hours 29 minutes ago

    Voting rights

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy